World Intellectual Property Organization

• The label, which controls about a third of the recorded music industry, has also been issuing substantial numbers of takedown requests in relation to AI uploads appearing online.
• It is the latest move in the music industry’s growing battle to prevent AIs from using its songs without licensing them.

AI music and copyright

• On a “royalty free music generator” like Mubert, it’s already possible to type in a prompt and the programme will use AI to search a catalogue of music for patterns.
• Music is protected by copyright law, which means that anyone wanting to use a song has to pay a licence.
• If AI programmes are using labels’ music catalogues without permission, they could be seen to have infringed music rights in at least two ways: by using the music to train the AIs, and in copying parts of the music that the AI produces from the training data.
• Unfortunately for the music industry, the UK government has been muddying the waters with proposals to change the copyright rules to benefit tech companies.

The battle for the UK

• The government did then appear to backtrack in February, with science minister George Freeman saying it would not take the exception forward.
• The white paper wants to prioritise making the UK a tech-friendly environment, emphasising “the role of regulation in creating the environment for AI to flourish”.
• Japan and Singapore are already introducing copyright exceptions along similar lines to those being discussed in the UK.
• It has also filed a case along the same lines in the UK, which is at an earlier stage.

• These business assets were spun out into a separate corporate entity as of October 1, 2021, therefore are not represented in the company’s year-to-date 2022 operating results.
• On December 9, 2022, completed a private placement and issued 905,660 common shares for gross proceeds of $480,000.
• On September 16, 2022, the Company completed a private placement and issued 1,754,386 common shares for gross proceeds of $1,000,000.
• Financial Results for the Year Ended December, 2022
  Net Loss: The net loss attributable to common stockholders was $11.56 million, from operations, or a basic and diluted loss per share of $(1.34).

• The application pertains to the development of a novel platform for loading Cannabinoids on Exosomes.
• The collaboration between Innocan and Ramot (Tel Aviv University's technology transfer company), is aimed at creating a drug delivery platform that maximizes the activity of loaded Cannabinoids.
• The new international patent application resulting from this joint effort is expected to expand the intellectual property space for cannabis-based products, opening exciting breakthrough opportunities.
• Commenting on this development, Iris Bincovich, CEO of Innocan Pharma Corporation, said, "We are delighted to announce this joint application with Ramot at Tel Aviv University.

• KronosMD believes this technology is the first of its kind and will improve the digital workflow of clear orthodontic aligner manufacturing.
• The filing of this provisional patent application directly relates to KronosMD's intellectual property development goals to manufacture and market an advanced and innovative dental ultrasound imaging product line.
• If approved, KronosMD believes this patent could significantly enhance manufacturing processes and workflows for the multi-billion clear orthodontic aligners market.
• The issued patents and the provisional patents are in two main fields, remote at-home digital virtual imaging devices, and office-based dental ultrasound imaging platforms and sensors, covering KronosMD disruptive 3D medical ultrasound products and software.